Clinical Trial Update: Sphingosine-1 Phosphate -Receptor Targeting and Microglial Activation

View source ↗

Summary

Turku University Hospital completed a clinical trial investigating sphingosine-1-phosphate receptor targeting and microglial activation in multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Turku University Hospital | Conditions: Multiple Sclerosis | Status: COMPLETED